Inbio ventures

About

Team biotech experience:

  • Over $200m deployed in early stage biotech companies through investments and strategic deals
  • 360˚ knowledge of the sector. Evolution stages: Academia, In-house Industrial R&D, Corporate VC and Business Development, Professional Regulated Public Equities Asset Management
  • 13 private early stage biotech companies invested (7 IPOs, 4 strategic deals, 2 M&A)
  • More than 20 public early stage biotech companies invested (3 strategic M&A, realized net cash IRR for investors up to 59%)
  • Deep scientific and biotech VC expertise (Institut Gustave Roussy, Moscow State University, Institute of Molecular Biology Russian Academy of Science, Research Centre of Biotechnology Russian Academy of Science)
  • Top positions in venture and production biotech companies in USA, Russia, Canada, EU: Pharmstandard, Generium, Aquinox, Protagonist, Codon, Allena, Transmedics and others